Extended-release Trazodone in Major Depressive Disorder: A Randomized, Double-blind, Placebo-controlled Study

Objective: To investigate the efficacy, safety, and clinical benefit of a once-daily formulation of trazodone (Trazodone Contramid(®) OAD) in the treatment of major depressive disorder. Design/Participants: In this double-blind study, 412 patients with major depressive disorder (Diagnostic and Stati...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Sheehan, David V., Croft, Harry A., Roderich Gossen, E., Levitt, Randy J., Brullé, Claire, Bouchard, Sylvie, Rozova, Anna
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Matrix Medical Communications 2009
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2719441/
https://ncbi.nlm.nih.gov/pubmed/19724732
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller